Sale strategies of pharmaceutical companies in a "pharmerging" country: the problems will not improve if the gaps remain.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Health Policy

• Publication date

  2012-08-01

• Fields of study

  Medicine, Business

• Identifiers
  DOI 10.1016/j.healthpol.2012.05.006PMID 22682762
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Educating Health Professionals about Drug and Device Promotion: Advocates' Recommendations

  2006cited by this paper
• Do drug firms hoodwink medical journals? Or is something wrong with the contribution and integrity of declared authors?

  2005cited by this paper
• A Survey of the Interactions Between Psychiatry Residency Programs and the Pharmaceutical Industry

  2005cited by this paper
• Drug companies frame rules to work with NHS

  2004cited by this paper
• CME and the pharmaceutical industry: two worlds, three views, four steps

  2004cited by this paper
• Pharma goes to the laundry: Public relations and the business of medical education.

  2004cited by this paper
• Drug company secretly briefed medical societies on HRT

  2003cited by this paper
• Unhealthy spin

  2003cited by this paper
• Information from drug companies and opinion leaders

  2003cited by this paper
• No more free lunches

  2003cited by this paper
• Evidence b(i)ased medicine—selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications

  2003cited by this paper
• Who pays for the pizza? Redefining the relationships between doctors and drug companies. 2: Disentanglement

  2003cited by this paper
• Relationships between the pharmaceutical industry and patients' organisations

  2003cited by this paper
• How to dance with porcupines: rules and guidelines on doctors' relations with drug companies

  2003cited by this paper
• Drug company sponsorship of education could be replaced at a fraction of its cost

  2003cited by this paper
• Medical journals and pharmaceutical companies: uneasy bedfellows

  2003cited by this paper
• Getting it right: industry sponsorship and medical research.

  2003cited by this paper
• Ethics of undisclosed payments to doctors recruiting patients in clinical trials.

  2002cited by this paper
• Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ

  2002cited by this paper
• Drug firms hype disease as sales ploy, industry chief claims

  2002cited by this paper
• For and against: Direct to consumer advertising is medicalising normal human experience: Against.

  2002cited by this paper
• Dances with the pharmaceutical industry.

  2002cited by this paper
• Diabetic care must improve

  2002cited by this paper
• Government launches intensive media campaign on MMR

  2002cited by this paper
• For and against: Direct to consumer advertising is medicalising normal human experience: For.

  2002cited by this paper
• Pharmaceutical Marketing: A Practical Guide

  2001cited by this paper
• NHS faces medical negligence bill of £2.6bn

  2001cited by this paper
• In brief

  2001cited by this paper
• Pfizer accused of testing new drug without ethical approval

  2001cited by this paper
• Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions.

  2001cited by this paper
• Physicians and the pharmaceutical industry: is a gift ever just a gift?

  2000cited by this paper
• Arabian nights—1001 tales of how pharmaceutical companies cater to the material needs of doctors: case report

  2000cited by this paper
• Medical societies accused of being beholden to the drugs industry

  1999cited by this paper
• Physicians, pharmaceutical sales representatives, and the cost of prescribing.

  1996cited by this paper
• Interactions between physicians and the pharmaceutical industry: what does the literature say?

  1993cited by this paper
• Doctors and Detailers: Therapeutic Education or Pharmaceutical Promotion?

  1989cited by this paper

• Access to healthcare in Russia: the role of socioeconomic factors and digital technologies

  2026cites this paper
• Key drivers of pharmaceutical sales in OECD countries

  2025cites this paper
• Assessing the effect of educational intervention on pharmaceutical promotion: a follow-up study among medical students from Pakistan

  2025cites this paper
• Assessing the effects of online educational intervention on pharmaceutical promotions: a pre–post study among medical and pharmacy students in Pakistan

  2025cites this paper
• Bibliometric Analysis of Bioethics and Medical Ethics Publications Originating from Türkiye

  2025cites this paper
• MARKET ACCESS FOR PHARMACEUTICALS IN TÜRKİYE: A COMPREHENSIVE OVERVIEW

  2025cites this paper
• The Effect of Unethical practices in Pharmaceutical Personal Selling on Physicians Prescription Decision: A Comparative Analysis based on Medical Representatives’ and Physicians’ Perspectives

  2024cites this paper
• Raising the bar for disclosure of industry payments to doctors

  2024cites this paper
• Analysis of the pharmaceutical market for sorption drugs in Russia and the European Union

  2024cites this paper
• Is the "social face" of AKP's pharmaceutical price reforms mostly instrumental? A progressivity analysis of household pharmaceutical expenditures in Turkey.

  2022cites this paper
• Developing a System Dynamic Model for Product Life Cycle Management of Generic Pharmaceutical Products: Its Relation with Open Innovation

  2022cites this paper
• Medical Representatives: Making the Digital Leap

  2021cites this paper
• Industrial and technological cooperation in pharmaceutical sector within the framework of EAEU: development of the model of legal regulation

  2021cites this paper
• Academic detailing program for rheumatoid arthritis: a contribution to Brazilian public health system sustainability

  2020cites this paper
• Understanding ethical/unethical behavior in pharmaceutical companies: a literature review

  2020cites this paper
• Compliance to prescribing guidelines among public health care facilities in Namibia; findings and implications

  2020cites this paper
• Análise da Evolução e Crescimento do Setor Farmacêutico no Brasil / Analysis of the Evolution and Growth of the Pharmaceutical Sector in Brazil

  2020cites this paper
• Promotion of Medicines in Low-and Middle-Income Countries

  2020cites this paper
• A follow-up study on the effects of an educational intervention against pharmaceutical promotion

  2020cites this paper
• Formulary Management Activities and Practice Implications Among Public Sector Hospital Pharmaceutical and Therapeutics Committees in a South African Province

  2020cites this paper
• Prescribing patterns of physicians working in both the direct and indirect treatment sectors in Iran; findings and implications

  2019cites this paper
• A multicenter point prevalence survey of antibiotic use in Punjab, Pakistan: findings and implications

  2019cites this paper
• Role of Health Technology Assessment in Pharmaceutical Market Access in Developed Countries

  2018cites this paper
• Extent of physician–pharmaceutical industry interactions in low- and middle-income countries: a systematic review

  2018cites this paper
• Drug promotional activities in Nigeria: impact on the prescribing patterns and practices of medical practitioners and the implications

  2018cites this paper
• Policy Change and the National Essential Medicines List Development Process in Brazil between 2000 and 2014: Has the Essential Medicine Concept been Abandoned?

  2018cites this paper
• Implementation and monitoring of decisions by pharmacy and therapeutics committees in South African public sector hospitals

  2018cites this paper
• Akunne, Onyinye Onyeka and Godman, Brian and Adedapo, Aduragbenro Deborah and Truter, Ilse and Fadare, Joseph (2016) Statin prescribing among hypertensive patients in south-west Nigeria : findings and implications

  2018cites this paper
• Drug and therapeutics committees in Nigeria: evaluation of scope and functionality

  2018cites this paper
• PHARMACEUTICAL AND BIOPHARMACEUTICAL PATENTS: AN OPPORTUNITY FOR FARMERGING COUNTRIES

  2018cites this paper
• Comparative Effectiveness and Safety of Monoclonal Antibodies (Bevacizumab, Cetuximab, and Panitumumab) in Combination with Chemotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis

  2018cites this paper
• One-day out-patient prescribing patterns at a national referral hospital in Kenya

  2017cites this paper
• Structure and activities of pharmacy and therapeutics committees among public hospitals in South Africa; findings and implications

  2017cites this paper
• Strategies for pricing of pharmaceuticals and generics in developing countries

  2017cites this paper
• A critical look at innovation profile and its relationship with pharmaceutical industry

  2017cites this paper
• Organizational and Economic Directions of Competitive Recovery of Russian Pharmaceutical Enterprises

  2016cites this paper
• Implementation of clinical guidelines in Brazil: should academic detailing be used?

  2016cites this paper
• Statin prescribing among hypertensive patients in southwest Nigeria: findings and implications for the future.

  2016cites this paper
• Knowledge, Beliefs and Attitudes of Patients and the General Public towards the Interactions of Physicians with the Pharmaceutical and the Device Industry: A Systematic Review

  2016cites this paper
• Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future

  2016cites this paper
• Clinical Effectiveness and Safety of Analog Glargine in Type 1 Diabetes: A Systematic Review and Meta-Analysis

  2016cites this paper
• The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians

  2016cites this paper
• Role of Word of Mouth Communication in North Cyprus: Painkillers and Dermocosmetics Products

  2015influential citation
• Physicians’ knowledge, perceptions and behaviour towards antibiotic prescribing: a systematic review of the literature

  2015cites this paper
• A INDÚSTRIA FARMACÊUTICA E A IMPORTÂNCIA ESTRATÉGICA DOS PROPAGANDISTAS DE MEDICAMENTOS: ESTUDO COM COLABORADORES EM NATAL/RN

  2014cites this paper
• Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs

  2014cites this paper
• Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications

  2014cites this paper
• EVOLUTION OF UNETHICAL PRACTICES IN THE SALES ENVIRONMENT : A macro story of pharmaceutical industry in Pakistan

  2014cites this paper
• Evaluation of Organizational Behavior - An application of the Typology of Miles and Snow in the Hotel sector Florianópolis - Santa Catarina - Brazil

  2013cites this paper
• Dabigatran – a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs

  2013influential citation
• Essential to increase the use of generics in Europe to maintain comprehensive health care

  2012cites this paper
• Repositório ISCTE-IUL

  year unknowncites this paper